Allscripts (MDRX) PT Lowered to $13 at Evercore ISI
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Allscripts (MDRX) PT Lowered to $14.50 at RBC Capital
May 4, 2018 8:20 AM EDTRBC Capital lowered its price target on Allscripts (NASDAQ: MDRX) to $14.50 (from $17.00) while maintaining a Outperform rating.
... MoreSunTrust Robinson Humphrey Upgrades Allscripts (MDRX) to Buy
May 4, 2018 7:10 AM EDTSunTrust Robinson Humphrey upgraded Allscripts (NASDAQ: MDRX) from Hold to Buy with a price target of $16.00.
For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.
Shares of Allscripts closed at $11.52 yesterday.
... MoreAllscripts (MDRX) to Buy HealthGrid
May 3, 2018 4:52 PM EDTAllscripts (NASDAQ: MDRX), a global leader in healthcare technology, today announced that it signed a definitive agreement to acquire HealthGrid Holding Company, a mobile enterprise patient engagement platform business. The agreement represents a significant expansion of the Allscripts FollowMyHealth® platform portfolio, the companys patient engagement solution focused on connecting patients with providers. Allscripts expects to close the acquisition in the second quarter of calendar 2018, subject to the satisfaction of customary closing conditions, including the expiration or termination of the waiting period under U.S. antitrust laws.
HealthGrid is a leading mobile, enterprise... More
Allscripts (MDRX) Misses Q1 EPS by 1c, Affirms Outlook
May 3, 2018 4:04 PM EDTAllscripts (NASDAQ: MDRX) reported Q1 EPS of $0.16, $0.01 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $518.6 million versus the consensus estimate of $530.48 million.
Allscripts affirms the following financial outlook for 2018
For earnings history and earnings-related data on Allscripts (MDRX) click here.
... More